Radiation-Induced Mucositis
12
2
2
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 12 trials
100.0%
+13.5% vs benchmark
17%
2 trials in Phase 3/4
0%
0 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (12)
A Randomized Controlled Study on the Improvement of Medical Experience for Patients With Radiation-induced Oropharyngeal Mucositis Based on the RIS System of the Internet of Things
Comparative Study of New Classification and Traditional Classification of Radioactive Oropharyngeal Mucositis
Effect of N-acetyl Cysteine and Zinc in Management of Head and Neck Cancer Radiotherapy Induced Oral Mucositis
Effects of Mesenchymal Stem Cell Supernatant on Prevention and Treatment of Skin/Mucosal Injury in Hematology Patients
Effectiveness of Topical Olive Oil in Prevention and Management of Radiation Induced Oral Mucositis
Opioid Therapy vs Multimodal Analgesia in Head and Neck Cancer
Curcumin Gel On Radiation Induced Oral Mucositis
Efficacy of Glutamine in Management of Radiation Mucositis
Steroid-Eluting Stent Implant for the Treatment of Radiation-Related Sinusitis
Effect of Nutritional Management on RIOM in Patients With Advanced Head and Neck Cancer
Benzydamine Oromucosal Solution in Oral Mucositis (BOOM)
The Effect of Alpha Lipoic Acid on the Incidence and Severity of Radiotherapy-Induced Oral Mucositis in Head and Neck Cancer Patients